Role of the Epstein-Barr virus in Hodgkin's disease;Role du virus d'Epstein-Barr dans la maladie de Hodgkin

Medecine Therapeutique

Volumn 6, Issue 1, 2000, Pages 14-18

  Raphaël, Martine ^a   Feuillard, Jean ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

APOPTOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HODGKIN DISEASE; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; VIRUS REPLICATION;

EID: 0033995721     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Kanzer H., Kuppers R., Hansman M.L., Rajewsky K. 1996. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184 : 1495-1505.
2. Carbone A., Gloghini A., Gaidano G., Franceschi S., Capello D., Drexler H., Falini B., Dalla-Favera R. 1998. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. Blood 92 : 2220-2228.
3. Jox A., Wolf J., Dielh V. 1997. Hodgkin's disease biology : recent advances. Hematol Oncol 15 : 165-171.
4. Jaffe E.S., Harris N.L., Diebold J., Muller-Hermelink H.K. 1999. World Health organization classification of neoplastic disease of the hematopoietic and lymphoid tissues A progress report. Am J Clin Pathol 111 (suppl.) : S8-S12.
5. Gutensohn (Mueller) N., Cole P. 1980. Epidemiology of Hodgkin's disease. Semin Oncol 7 : 92-102.
6. Mueller N., Evans A., Harris N L., Comstock G.W., Jellum E., Magnus K., et al. 1989. Hodgkin's disease and EBV : altered antibody pattern before diagnosis. N Engl J Med 320 : 696-701
7. Weiss L., Movahed L.A., Warnke R.A., Sklar J. 1989. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320 : 502-506.
8. Brousset P., Chittal S., Schlaifer D., Icart J., Payen C., Rigal-Huguet F., Voigt J.J., Delsoi G. 1991. Detection of Epstein-barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAmeX) sections. Blood 77 : 1781-1787.
9. Rowe D.T. 1999. Epstein-Barr virus immortalization and latency. Frontiers in Bioscience 4 : 346-371
10. Brousset P., Meggetto F., Knecht H., Schlaifer D., Mariame B., Selves J., Bibeau F., Delsol G. 1995. Implication du virus d'Epstein-Barr dans la maladie de Hodgkin. Hématologie 3 : 219-226.
11. Pallesen G., Hamilton-Dutoit S.J., Zhou X. 1993. The association of Epstein-Barr virus (EBV) with Tcell lymphoproliferations and Hodgkin's disease : two new developments in the EBV field. Advances in Cancer Res 62 : 179-239.
12. Razzouk B.I., Gan Y.J., Mendonca C., Jen kins J.J., Liu Q., Hudson M., Sixbey J.W., Ribeiro R.C. 1997. Epstein-Barr virus in pediatric Hodgkin disease : age and histiotype are more predictive than geographic region. Med Pediatr Oncol 28 : 248-254.
13. Brousset P., Schlaifer D., Meggetto F., Bachmann E., Rothenberger S., Pris J., Delsol G., Knecht H. 1994. Persistence of the same viral strain in early and late relapses of Epstein-Barr virus-associated Hodgkin's disease. Blood 84 : 2447-2451.
14. Lin J.C., Lin S.C., De B.K., Chan W.P., Evatt B.L. 1993. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER) : predominance of type A virus associated with Hodgkin's disease. Blood 81 : 3372-3381.
15. Boyle M.J , Vasak E., Tschuching G.M. 1993. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's diseases : association between B-type EBV and immunocompromise. Blood 81 : 468-474.
16. Niedobitek G., Kremmer E., Herbst H., Whitehead L., Dawson X.W., Von Ostau C.V., Rooney N., Grässer F.A., Young L.S. 1997. Immunohistochemical detection of the Epstein-Barr virus encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood 90 : 1664-1672.
17. Deacon M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A., Young L.S. 1993. Epstein-Barr virus and Hodgkin's disease : transcriptional analysis of virus latency in the malignant cellls. J Exp Med 177 : 339-349.
18. Grasser F., Murray P.G., Kremmer E., Klein K., Remberger K., Feiden W., Reynolds G., Niedobitek G., Young L.S., Mueller-Lantzsch N. 1994. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1) : immunohislogic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 84 : 3792-3798.
19. Chang K.L., Chen Y.Y., Chen W.G., Hayashi K., Bacchi C., Bacchi M., Weiss L.M. 1999. EBNA-1 gene sequences in Brazilian and American patients with Hodgkin's disease. Blood 94 : 244-250.
20. Knecht H., McQuain C., Martin J., Rotheberger S , Drexler H.G., Berger C., Bachman E., Kittler E.L.W., Odermatt B.H., Quesenberry P.J. 1996. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Oncogene 13 : 947-953.
21. Liebowitz D. 1998. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 338 : 1413-1421.
22. May M.J., Ghosh S. 1997. Rel/NF-kB and IkB proteins : an overview. Cancer Biol 8 : 63-73.
23. Dürkop H., Foss H.D., Demel G., Klotzbach H., Hahn C., Stein H. 1999. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus transformed lymphoid cells. Blood 93 : 617-623.
24. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. 1998. NF-kB antiapoptotis : induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281 : 1680-1683.
25. Krappman D., Emmerich F., Scharschmidt E., Dörken B., Scheidereit C. 1999. Molecular mechanisms of constitutive NF-kB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 18 : 943-953.
26. Wood K.M., Roff M., Hay R.T. 1998. Defective IkBa in Hodgkin cell lines with constitutive active NF-kB. Oncogene 16 : 2131-2139.
27. Bargou R.C., Emmerich F., Krappman D., Bommert K., Mapara M.Y., Arnold W., Royer H.D., Grinstein E., Greiner A., Scheidereit C, Dörken B. 1997. Constitutive nuclear factor-kB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 12 : 2961-2969.
28. Hayashi K., Chen W.G., Chen Y.Y., Bacchi M.M., Carlos E., Bacchi C.E., Alvarenga M., Abreu E.S., Chang K.L., Weiss L.W. 1997. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brezilian Hodgkin's disease and reactive lymphoid tissue : high frequency of a 30-bp deletion. Hum Pathol 28 : 1408-1414.
29. Brousset P., Knecht H., Rubin B., Drouet E., Chittal S., Meggetto F., Al Saati T., Bachmann E., Denoyel G., Sergeant A., Delsol G. 1993. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood 82 : 872-876.
30. Trivedi P., Hu L., Chen F., Christensson B., Masucci M.G., Klein G., Winberg G. 1994. The EBV encoded membran protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system in contrast to a B-cell derived homologue. Eur J Cancer 30A : 84-88.
31. Frisan T., Sjöberg J., Dolcetti R., Boiocchi M., De Re V., Carbone A., Brautbar C., Battat S., Biberfeld P., Eckman M., Ost A., Christensson B., Sundström C., Björkholm M., Pisa P., Masucci M. 1995. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86 : 1493-1501.
32. Herbst H., Foss H.D., Samol J., Araujo I., Klotcbach H., Krause H., Agathanggelou A., Niedobitek G., Stein H. 1996. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 87 : 2918-2929.
33. Lee S.P., Constandinou C.M., Thomas W.A., Croom-Carter D., Blake N.W., Murray P.G., Crocker J., Rickinson A. 1998. Antigen presenting phenotype of HodgkinReed-Sternberg cells : analysis of the HLA class Iprocessing pathway and the effects of interleukin-10 on Epstein-Barr virus specific cytotoxic T-cell recognition. Blood 92 : 1020-1030.
34. Murray P.G., Constandinou C.M., Crocker J., Young L.S., Ambinder R.F. 1998. Analysis of major histocompatibility complex class I, TAP expression and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease. Blood 92 : 2477-2483.
35. Morenter M., Piris M., Abraira V., Acevedo A., Aguilera B., Bellas C., Fraga M., Garcia-Del-Moral R., Gomez-Marcos F., Menaguez J., Oliva H., Sanchez-Beato M., Montalban C. 1997. Adverse outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index and absence of Epstein-Barr virus latent-membrane protein 1 expression. Blood 90 : 2429-2436.
36. Murray P.G., Billingham L.J., Hassan H.T., Flavell J.R., Nelson P.N., Scott K., Reynolds G., Constandinou C.M., Kerr D.J., Devey E.C., Crocker J., Young L.S. 1999. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood 94 : 442-447.